Anteris Technologies Global (ASX:AVR) was admitted to the official list of the Australian Securities Exchange Monday, according to a same-day filing with the Australian bourse.
The move was made following parent biotechnology firm Anteris Group's decision to re-domicile in the US from Australia.
Anteris Technologies Global expects its CHESS depositary interest will start quotation on Dec. 17, the filing said.
It expects to raise $88.8 million via its initial public offer on the Nasdaq which is expected to close on Monday, the filing added.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。